1. Market Research
  2. > Pharmaceutical Market Trends
  3. > France Pharmaceuticals and Healthcare Report Q1 2016

France Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 125 pages

Includes 3 FREE quarterly updates

BMI View: The uptick in private consumption and economic growth in France will benefit thepharmaceutical and healthcare sector through the coming quarters. However, despite an improvingregional and domestic economic environment, France's pharmaceutical market growth is expected toremain in negative territory in 2016, before it resumes expansion. Meanwhile, fixed investment rates arealso expected to recover in 2016, although structural impediments will continue to hinder a moresignificant upturn in activity in the near term, including in the pharmaceutical sector.

Headline Expenditure Projections

- Pharmaceuticals: EUR33.69bn (USD45.14bn) in 2014 to EUR33.46bn (USD36.80bn) in 2015; -0.7% inlocal currency terms and -18.5% in US dollar terms. Forecast in line with last quarter.

- Healthcare: EUR246.20bn (USD329.91bn) in 2014 to EUR253.47bn (USD278.82bn) in 2015; +3.0% inlocal currency terms and -15.5% in US dollar terms. Forecast in line with last quarter.

Table Of Contents

France Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (France 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (France 2011-2019) 15
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (France 2011-2019) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (France 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (France 2011-2019) 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (France 2011-2019) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (France 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (France 2011-2019) 28
OTC Medicine Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (France 2011-2019) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (France 2013-2019) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (France 2013-2019) 34
Industry Risk/Reward Index 35
Western Europe Risk/Reward Index 35
France Risk/Reward Index 41
Rewards 41
Risks 41
Regulatory Review 43
Intellectual Property Issues 45
Pricing and Reimbursement 46
Table: France Reimbursement Categories 47
Market Overview 57
Healthcare Sector 58
Table: Hospital Activity, 2005-2009 65
Table: Hospital Activity in Short-Stay Units, 2009 66
Table: Diagnostic and Therapeutic Procedures Performed In Public and Private Hospitals, 2009 67
Table: Projected Regional Ranking Of Physicians, 2017 68
Table: Health Status 69
Table: Healthcare Funding 69
Table: Healthcare Resources (France 2009-2014) 70
Table: Healthcare Personnel (France 2009-2014) 70
Table: Healthcare Activity (France 2009-2014) 71
Research and Development 71
Clinical Trials 75
Epidemiology 77
Competitive Landscape 80
Research-Based Industry 80
Table: Table: Multinational Market Activity 83
Generic Drugmakers 85
Pharmaceutical Distribution 85
Pharmaceutical Retail Sector 86
Company Profile 88
GlaxoSmithKline 88
Ipsen 91
Merck and Co 95
Novartis 97
Sanofi 100
Servier 109
Demographic Forecast 114
Table: Population Headline Indicators (France 1990-2025) 115
Table: Key Population Ratios (France 1990-2025) 115
Table: Urban/Rural Population and Life Expectancy (France 1990-2025) 116
Table: Population By Age Group (France 1990-2025) 116
Table: Population By Age Group % (France 1990-2025) 117
Glossary 119
Methodology 121
Pharmaceutical Expenditure Forecast Model 121
Healthcare Expenditure Forecast Model 121
Notes On Methodology 122
Risk/Reward Index Methodology 123
Index Overview 124
Table: Pharmaceutical Risk/Reward Index Indicators 124
Indicator Weightings 125

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.